These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 16365082)

  • 21. Interaction of dietary composition and PYY gene expression in diet-induced obesity in rats.
    Yang N; Wang C; Xu M; Mao L; Liu L; Sun X
    J Huazhong Univ Sci Technolog Med Sci; 2005; 25(3):243-6. PubMed ID: 16201260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peptide YY ablation in mice leads to the development of hyperinsulinaemia and obesity.
    Boey D; Lin S; Karl T; Baldock P; Lee N; Enriquez R; Couzens M; Slack K; Dallmann R; Sainsbury A; Herzog H
    Diabetologia; 2006 Jun; 49(6):1360-70. PubMed ID: 16680491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of chronic oral rimonabant administration on energy budgets of diet-induced obese C57BL/6 mice.
    Zhang LN; Gamo Y; Sinclair R; Mitchell SE; Morgan DG; Clapham JC; Speakman JR
    Obesity (Silver Spring); 2012 May; 20(5):954-62. PubMed ID: 22173576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. L-arginine promotes gut hormone release and reduces food intake in rodents.
    Alamshah A; McGavigan AK; Spreckley E; Kinsey-Jones JS; Amin A; Tough IR; O'Hara HC; Moolla A; Banks K; France R; Hyberg G; Norton M; Cheong W; Lehmann A; Bloom SR; Cox HM; Murphy KG
    Diabetes Obes Metab; 2016 May; 18(5):508-18. PubMed ID: 26863991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peptide YY containing enteroendocrine cells and peripheral tissue sensitivity to PYY and PYY(3-36) are maintained in diet-induced obese and diet-resistant rats.
    Hyland NP; Pittman QJ; Sharkey KA
    Peptides; 2007 Jun; 28(6):1185-90. PubMed ID: 17475366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NPY modulates PYY function in the regulation of energy balance and glucose homeostasis.
    Zhang L; Nguyen AD; Lee IC; Yulyaningsih E; Riepler SJ; Stehrer B; Enriquez RF; Lin S; Shi YC; Baldock PA; Sainsbury A; Herzog H
    Diabetes Obes Metab; 2012 Aug; 14(8):727-36. PubMed ID: 22369253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mice lacking pro-opiomelanocortin are sensitive to high-fat feeding but respond normally to the acute anorectic effects of peptide-YY(3-36).
    Challis BG; Coll AP; Yeo GS; Pinnock SB; Dickson SL; Thresher RR; Dixon J; Zahn D; Rochford JJ; White A; Oliver RL; Millington G; Aparicio SA; Colledge WH; Russ AP; Carlton MB; O'Rahilly S
    Proc Natl Acad Sci U S A; 2004 Mar; 101(13):4695-700. PubMed ID: 15070780
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dietary whey protein decreases food intake and body fat in rats.
    Zhou J; Keenan MJ; Losso JN; Raggio AM; Shen L; McCutcheon KL; Tulley RT; Blackman MR; Martin RJ
    Obesity (Silver Spring); 2011 Aug; 19(8):1568-73. PubMed ID: 21331067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peptide YY: food for thought.
    Neary MT; Batterham RL
    Physiol Behav; 2009 Jul; 97(5):616-9. PubMed ID: 19268484
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Attenuated peptide YY release in obese subjects is associated with reduced satiety.
    le Roux CW; Batterham RL; Aylwin SJ; Patterson M; Borg CM; Wynne KJ; Kent A; Vincent RP; Gardiner J; Ghatei MA; Bloom SR
    Endocrinology; 2006 Jan; 147(1):3-8. PubMed ID: 16166213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peptide designed to elicit apoptosis in adipose tissue endothelium reduces food intake and body weight.
    Kim DH; Woods SC; Seeley RJ
    Diabetes; 2010 Apr; 59(4):907-15. PubMed ID: 20103704
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peripheral exendin-4 and peptide YY(3-36) synergistically reduce food intake through different mechanisms in mice.
    Talsania T; Anini Y; Siu S; Drucker DJ; Brubaker PL
    Endocrinology; 2005 Sep; 146(9):3748-56. PubMed ID: 15932924
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiobesity effects of the beta-cell hormone amylin in diet-induced obese rats: effects on food intake, body weight, composition, energy expenditure, and gene expression.
    Roth JD; Hughes H; Kendall E; Baron AD; Anderson CM
    Endocrinology; 2006 Dec; 147(12):5855-64. PubMed ID: 16935845
    [TBL] [Abstract][Full Text] [Related]  

  • 34. GIP receptor deletion in mice confers resistance to high-fat diet-induced obesity via alterations in energy expenditure and adipose tissue lipid metabolism.
    Boer GA; Keenan SN; Miotto PM; Holst JJ; Watt MJ
    Am J Physiol Endocrinol Metab; 2021 Apr; 320(4):E835-E845. PubMed ID: 33645252
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EGLP-1 lowers body weight better than exendin-4 by reducing food intake and increasing basal energy expenditure in diet-induced obese mice.
    Gao H; Zhao Q; Li K; Qin F; Yin X; Lu Z; Song Z; Wu Y; Shen Y; Pan Y; Jin L; Yanfeng Zhang
    Exp Cell Res; 2021 Feb; 399(1):112454. PubMed ID: 33359447
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Eicosapentaenoic acid reduces adipocyte hypertrophy and inflammation in diet-induced obese mice in an adiposity-independent manner.
    LeMieux MJ; Kalupahana NS; Scoggin S; Moustaid-Moussa N
    J Nutr; 2015 Mar; 145(3):411-7. PubMed ID: 25733455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of peptide YY in appetite regulation and obesity.
    Karra E; Chandarana K; Batterham RL
    J Physiol; 2009 Jan; 587(1):19-25. PubMed ID: 19064614
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dietary fat and gut microbiota interactions determine diet-induced obesity in mice.
    Kübeck R; Bonet-Ripoll C; Hoffmann C; Walker A; Müller VM; Schüppel VL; Lagkouvardos I; Scholz B; Engel KH; Daniel H; Schmitt-Kopplin P; Haller D; Clavel T; Klingenspor M
    Mol Metab; 2016 Dec; 5(12):1162-1174. PubMed ID: 27900259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively.
    Neary NM; Small CJ; Druce MR; Park AJ; Ellis SM; Semjonous NM; Dakin CL; Filipsson K; Wang F; Kent AS; Frost GS; Ghatei MA; Bloom SR
    Endocrinology; 2005 Dec; 146(12):5120-7. PubMed ID: 16150917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ghrelin but not peptide YY is related to change in body weight and energy availability.
    Scheid JL; De Souza MJ; Leidy HJ; Williams NI
    Med Sci Sports Exerc; 2011 Nov; 43(11):2063-71. PubMed ID: 21502892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.